Be in the know. 20 key reads for Thursday…

  1. What’s In Store For Biogen If Alzheimer’s Drug Gains FDA Approval? (Investor’s Business Daily)
  2. 2022 Defense Department Budget Bodes Well for 4 Top Stocks to Buy Now (247wallst)
  3. This Nobel Laureate In Physics Looks To The Next Huge Thing (Investor’s Business Daily)
  4. Alibaba, Alphabet, and Amazon Stock Are Bargains, This Value Manager Says (Barron’s)
  5. Discovery’s ‘K’ Shares Are One Way to Play the Merger With Warner Media (Barron’s)
  6. Business Travel Is Coming Back (Wall Street Journal)
  7. Traveling to Europe? Here’s What’s Open to U.S. Tourists (Wall Street Journal)
  8. Elon Musk’s Starlink Could Get Boost From German Subsidies (Wall Street Journal)
  9. No Grave Dancing for Sam Zell Now. He’s Paying Up for Hot Properties. (Wall Street Journal)
  10. The Fed announces plans to sell off its corporate bond holdings. (New York Times)
  11. AMC files to sell 11 million shares (CNBC)
  12. Jack Ma’s Ant Group gets China’s approval to operate consumer finance firm (CNBC)
  13. US weekly jobless claims tumble to new pandemic-era low of 385,000 (Business Insider)
  14. Fed’s Beige Book sees pickup in U.S. economic growth (MarketWatch)
  15. United Plans to Buy 15 Supersonic Planes (Wall Street Journal)
  16. Carbon Price Boom Attracts Investors to Emissions-Trading Market (Wall Street Journal)
  17. Tracking Covid-19 Vaccine Distribution (Wall Street Journal)
  18. World Food Prices at 10-Year Highs in May, Says United Nations Food Agency, Biggest Monthly Jump Since 2010 (Street Insider)
  19. Tellurian signs 10-year LNG agreement with Vitol for 3 MTPA (Reuters)
  20. Spac promoter Palihapitiya seeks $800m to target biotech companies (Financial Times)